Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
ARS Pharmaceuticals Inc. (NASDAQ : SPRY) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis.
Quote
| Last: | $8.56 |
|---|---|
| Change Percent: | -5.31% |
| Open: | $9 |
| Close: | $9.04 |
| High: | $9.1008 |
| Low: | $8.56 |
| Volume: | 280,184 |
| Last Trade Date Time: | 06/05/2026 12:45:46 pm |
Stock Data
| Market Cap: | $980,578,221 |
|---|---|
| Float: | 54,762,130 |
| Insiders Ownership: | 4.62% |
| Institutions: | 62 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.ars-pharma.com |
| Country: | US |
| City: | San Diego |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about ARS Pharmaceuticals Inc. (NASDAQ: SPRY).
